Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
503.84
-5.60 (-1.10%)
At close: Sep 30, 2026, 4:00 PM EDT
503.96
+0.12 (0.02%)
After-hours: Sep 30, 2026, 7:30 PM EDT
Madrigal Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of $11.64 billion as of September 30, 2026. Its market cap has increased by 17.87% in one year.
Market Cap
11.64B
Enterprise Value
11.15B
1-Year Change
17.87%
Ranking
Category
Stock Price
$503.84
ChartMarket Cap Chart
Since February 6, 2007, Madrigal Pharmaceuticals's market cap has increased from $297.50M to $11.64B, an increase of 3,812.87%. That is a compound annual growth rate of 20.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.64B | -11.98% |
| Dec 31, 2025 | 13.23B | 96.52% |
| Dec 31, 2024 | 6.73B | 47.33% |
| Dec 29, 2023 | 4.57B | -7.98% |
| Dec 30, 2022 | 4.96B | 242.65% |
| Dec 31, 2021 | 1.45B | -15.74% |
| Dec 31, 2020 | 1.72B | 22.31% |
| Dec 31, 2019 | 1.41B | -18.98% |
| Dec 31, 2018 | 1.74B | 51.27% |
| Dec 29, 2017 | 1.15B | 565.31% |
| Dec 30, 2016 | 172.40M | 255.46% |
| Dec 31, 2015 | 48.50M | -83.19% |
| Dec 31, 2014 | 288.60M | -20.30% |
| Dec 31, 2013 | 362.10M | -35.14% |
| Dec 31, 2012 | 558.30M | 141.48% |
| Dec 30, 2011 | 231.20M | -6.85% |
| Dec 31, 2010 | 248.20M | 44.39% |
| Dec 31, 2009 | 171.90M | -17.20% |
| Dec 31, 2008 | 207.60M | -8.55% |
| Dec 31, 2007 | 227.00M | -23.70% |
| Feb 6, 2007 | 297.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascendis Pharma | 14.82B |
| Exelixis | 14.41B |
| Halozyme Therapeutics | 12.93B |
| BridgeBio Pharma | 12.82B |
| Corcept Therapeutics | 12.55B |
| Summit Therapeutics | 12.45B |
| BioMarin Pharmaceutical | 11.66B |
| Twist Bioscience | 11.46B |